153 related articles for article (PubMed ID: 17364475)
61. A solid-phase adsorption method for PEGylation of human serum albumin and staphylokinase: preparation, purification and biochemical characterization.
Suo X; Lu X; Hu T; Ma G; Su Z
Biotechnol Lett; 2009 Aug; 31(8):1191-6. PubMed ID: 19343505
[TBL] [Abstract][Full Text] [Related]
62. Obstacles and pitfalls in the PEGylation of therapeutic proteins.
Gaberc-Porekar V; Zore I; Podobnik B; Menart V
Curr Opin Drug Discov Devel; 2008 Mar; 11(2):242-50. PubMed ID: 18283612
[TBL] [Abstract][Full Text] [Related]
63. Effects of cell-penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs.
Nguyen J; Xie X; Neu M; Dumitrascu R; Reul R; Sitterberg J; Bakowsky U; Schermuly R; Fink L; Schmehl T; Gessler T; Seeger W; Kissel T
J Gene Med; 2008 Nov; 10(11):1236-46. PubMed ID: 18780309
[TBL] [Abstract][Full Text] [Related]
64. The decrease of PAMAM dendrimer-induced cytotoxicity by PEGylation via attenuation of oxidative stress.
Wang W; Xiong W; Wan J; Sun X; Xu H; Yang X
Nanotechnology; 2009 Mar; 20(10):105103. PubMed ID: 19417510
[TBL] [Abstract][Full Text] [Related]
65. Reversible pegylation prolongs the hypotensive effect of atrial natriuretic peptide.
Nesher M; Vachutinsky Y; Fridkin G; Schwarz Y; Sasson K; Fridkin M; Shechter Y; Lichtstein D
Bioconjug Chem; 2008 Jan; 19(1):342-8. PubMed ID: 18069777
[TBL] [Abstract][Full Text] [Related]
66. Emerging PEGylated drugs.
Kang JS; Deluca PP; Lee KC
Expert Opin Emerg Drugs; 2009 Jun; 14(2):363-80. PubMed ID: 19453284
[TBL] [Abstract][Full Text] [Related]
67. Mannosamine-biotin as a novel masking agent for coating IgG for immune response silencing and augmentation of antibody-antigen interaction.
Vaya J; Aizenshtein E; Khatib S; Gefen T; Fassler M; Musa R; Krispel S; Pitcovski J
Vaccine; 2009 Nov; 27(49):6869-76. PubMed ID: 19765399
[TBL] [Abstract][Full Text] [Related]
68. Binding enhancement of antigen-functionalized PEGylated gold nanoparticles onto antibody-immobilized surface by increasing the functionalized antigen using alpha-sulfanyl-omega-amino-PEG.
Yoshimoto K; Hoshino Y; Ishii T; Nagasaki Y
Chem Commun (Camb); 2008 Nov; (42):5369-71. PubMed ID: 18985213
[TBL] [Abstract][Full Text] [Related]
69. Immune complex binding by immunocamouflaged [poly(ethylene glycol)-grafted] erythrocytes.
Bradley AJ; Scott MD
Am J Hematol; 2007 Nov; 82(11):970-5. PubMed ID: 17654505
[TBL] [Abstract][Full Text] [Related]
70. Non-conservative surface decoration of hemoglobin: influence of neutralization of positive charges at PEGylation sites on molecular and functional properties of PEGylated hemoglobin.
Li D; Hu T; Manjula BN; Acharya SA
Biochim Biophys Acta; 2008 Oct; 1784(10):1395-401. PubMed ID: 18452721
[TBL] [Abstract][Full Text] [Related]
71. Characterization of poly(ethylene glycol) and PEGylated products by LC/MS with postcolumn addition of amines.
Huang L; Gough PC; Defelippis MR
Anal Chem; 2009 Jan; 81(2):567-77. PubMed ID: 19072225
[TBL] [Abstract][Full Text] [Related]
72. Immunogenicity of murine mPEG-red blood cells and the risk of anti-PEG antibodies in human blood donors.
Le Y; Toyofuku WM; Scott MD
Exp Hematol; 2017 Mar; 47():36-47.e2. PubMed ID: 27864153
[TBL] [Abstract][Full Text] [Related]
73. Virioplankton 'pegylation': use of PEG (polyethylene glycol) to concentrate and purify viruses in pelagic ecosystems.
Colombet J; Robin A; Lavie L; Bettarel Y; Cauchie HM; Sime-Ngando T
J Microbiol Methods; 2007 Dec; 71(3):212-9. PubMed ID: 17897741
[TBL] [Abstract][Full Text] [Related]
74. Biosynthesis, properties and potential of natural-synthetic hybrids of polyhydroxyalkanoates and polyethylene glycols.
Foster LJ
Appl Microbiol Biotechnol; 2007 Jul; 75(6):1241-7. PubMed ID: 17457543
[TBL] [Abstract][Full Text] [Related]
75. Structural Stability and Biophysical Properties of the Mega-Protein Erythrocruorin Are Regulated by Polyethylene Glycol Surface Coverage.
Savla C; Palmer AF
Biomacromolecules; 2021 May; 22(5):2081-2093. PubMed ID: 33821616
[TBL] [Abstract][Full Text] [Related]
76. Experience in the detection of red cell antigens and HLA antigens in bloodstains.
Lincoln PJ; Dodd BE
Haematologia (Budap); 1984; 17(2):299-305. PubMed ID: 6534833
[TBL] [Abstract][Full Text] [Related]
77. The encapsulation and release of guanosine from PEGylated liposomes.
Er Y; Barnes TJ; Fornasiero D; Prestidge CA
J Liposome Res; 2009; 19(1):29-36. PubMed ID: 19515005
[TBL] [Abstract][Full Text] [Related]
78. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
[TBL] [Abstract][Full Text] [Related]
79. Effect of pegylation on pharmaceuticals.
Harris JM; Chess RB
Nat Rev Drug Discov; 2003 Mar; 2(3):214-21. PubMed ID: 12612647
[TBL] [Abstract][Full Text] [Related]
80. Ultrasound assisted siRNA delivery using PEG-siPlex loaded microbubbles.
Vandenbroucke RE; Lentacker I; Demeester J; De Smedt SC; Sanders NN
J Control Release; 2008 Mar; 126(3):265-73. PubMed ID: 18237813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
